ArticleOncology research2026

Targeting Aurora A Kinase Enhance the CDK4/6 Inhibitor Sensitivity in HR+/HER2- Breast Cancer.

Juan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.